Portosystemic shunt is an effective treatment for complications of portal hypertension in hepatic myeloid metaplasia and improves nutritional status
Paola Guglielmelli
Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy
Center Research Innovation of Myeloproliferative Neoplasms (CRIMM), SOD Hematology, University of Florence, Italy
Center for Research, High Education and Transfer DENOThe, University of Florence, Florence, Italy
Search for more papers by this author
Comments (0)